NCT06717204View on ClinicalTrials.gov

Vericiguat for Heart Failure With Reduced Ejection Fraction After Myocardial Infarction

Not yet recruitingOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
HFrEF - Heart Failure With Reduced Ejection FractionMyocardial Infarction (MI)
Interventions
DRUG

Vericiguat Oral Tablet [Verquvo]

Vericiguat in addition to conventional treatment

DRUG

Prescription Drugs

Conventional treatment only

Trial Locations (3)

250012

Qilu Hospital of Shandong University, Jinan

250013

Central Hospital Affiliated to Shandong First Medical University, Jinan

250031

The First Affiliated Hospital of Shandong First Medical University/Shandong Province Qianfoshan Hospital, Jinan

All Listed Sponsors
collaborator

Jinan Central Hospital

OTHER

collaborator

Qianfoshan Hospital

OTHER

lead

Qilu Hospital of Shandong University

OTHER

NCT06717204 - Vericiguat for Heart Failure With Reduced Ejection Fraction After Myocardial Infarction | Biotech Hunter | Biotech Hunter